Filter by Year:
Press Releases
-
May 26, 2021
Foghorn Therapeutics to Present in Two Upcoming Investor Conferences
-
May 17, 2021
Foghorn Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Program of FHD-286
-
May 11, 2021
Foghorn Therapeutics Provides Corporate Update
-
Apr 28, 2021
Foghorn Therapeutics Appoints Ian Smith to its Board of Directors
-
Mar 18, 2021
Foghorn Therapeutics Provides Corporate Update
-
Mar 11, 2021
UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
-
Feb 22, 2021
Foghorn Therapeutics to Participate in the 41st Cowen Annual Healthcare Conference
Displaying 11 - 17 of 17